Search Results for 'Heparin-Rivaroxaban'

Heparin-Rivaroxaban published presentations and documents on DocSlides.

Thromboembolic protocols
Thromboembolic protocols
by cecilia
& safe anticoagulant prescribing. July 2020. D...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
Rivaroxaban compared with enoxaparin for the prevention of
Rivaroxaban compared with enoxaparin for the prevention of
by luanne-stotts
Alexander T Cohen . On behalf of the MAGELLAN Ste...
Efficacy and Safety of Low Molecular Weight Heparin compared to Unfractionated Heparin for Chronic
Efficacy and Safety of Low Molecular Weight Heparin compared to Unfractionated Heparin for Chronic
by mitsue-stanley
R. eview and Meta-Analysis.. Dinesh Keerty, MD. T...
HEPARIN INDUCED THROMBOCYTOPENIA
HEPARIN INDUCED THROMBOCYTOPENIA
by ellena-manuel
(HIT). HEPARIN-INDUCED THROMBOCYTOPENIA. Unfracti...
Reversing Course:  Managing Anticoagulation and Antiplatelet Bleeding
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
by kyle585
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
Review on NOACs Studies Dr.
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
MAGELLAN Primary efficacy endpoint  at 10 days (DVT, symptomatic PE,
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
by HoneyBun
VTE death. ) for . rivaroxaban. vs. . enoxaparin....
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...
Rivaroxaban in stable peripheral or carotid artery disease
Rivaroxaban in stable peripheral or carotid artery disease
by basidell
Sonia Anand, on . behalf of the COMPASS Steering C...
A ssessment of  D ual antiplatelet therapy versus
A ssessment of D ual antiplatelet therapy versus
by coursion
R. ivaroxaban . I. n atrial . F. ibrillation patie...
Ima  A.  Kusuma , MD, FIHA
Ima A. Kusuma , MD, FIHA
by hirook
“JIH. ” Hospital, Yogyakarta, Indonesia. The U...
A ssessment of  D ual antiplatelet therapy versus
A ssessment of D ual antiplatelet therapy versus
by stefany-barnette
A ssessment of D ual antiplatelet therapy versus...
Dr. Phil Wells  on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
CAD/PAD in Primary Care CV Risk in Stable Outpatients
CAD/PAD in Primary Care CV Risk in Stable Outpatients
by stefany-barnette
Stratified by Baseline CV Risk Category. Aspirin ...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Stroke, Bleeding, and
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
New Oral Anticoagulant
New Oral Anticoagulant
by mitsue-stanley
R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...
R eal-world
R eal-world
by liane-varnes
EVI. dence. on . S. troke prevention . I. n pati...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Novel Oral Anticoagulants
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
Recent  ACS: STEMI, NSTEMI, UA
Recent ACS: STEMI, NSTEMI, UA
by danika-pritchard
Stabilized 1-7 Days Post-Index Event. Exclusions:...
Depolymerization of heparin benzyl ester in a flow system
Depolymerization of heparin benzyl ester in a flow system
by brooke
Richard T. Taylor* and Rebecca G. Brunner. Departm...
Approach to thrombocytopenia
Approach to thrombocytopenia
by eleanor
. jithin. P JR1 Medicine. introduction. P. latel...
8:   Anticoagulants   Introduction about coagulation cascade
8: Anticoagulants Introduction about coagulation cascade
by ethlyn
. Classify drugs acting as anticoagulants. . Elab...
Semen Dynamics Dr. Pramod Kumar
Semen Dynamics Dr. Pramod Kumar
by lam
Department of Veterinary Physiology. BVC, Patna. C...
ORAL SURGERY IN PATIENTS ON ANTICOAGULANT THERAPY
ORAL SURGERY IN PATIENTS ON ANTICOAGULANT THERAPY
by eloise
Presented by-. Dr. Varun Mittal, PG. Dept of Maxil...
SLE with Secondary APLA Complicating Pregnancy
SLE with Secondary APLA Complicating Pregnancy
by josephine
Presentor. . Dr. . B.Sreevidya. FNB Resident, Fer...
Diagnosis Thrombocytopenia HITA POCKET GUIDE FOR THE CLINICIAN DECEM
Diagnosis Thrombocytopenia HITA POCKET GUIDE FOR THE CLINICIAN DECEM
by evelyn
ASH CLINICAL PRACTICE GUIDELINESVENOUS THROMBOEMBO...
Introduction
Introduction
by elizabeth
This s tandard applies to inpatients aged over 16...
Guidelines for Using Bivalirudin During Cardiopulmonary Bypass Surgery
Guidelines for Using Bivalirudin During Cardiopulmonary Bypass Surgery
by brooke
During cardiopulmonary bypass procedures, systemic...
  Venous Thromboembolism (VTE) in pregnancy
  Venous Thromboembolism (VTE) in pregnancy
by RainbowGlow
Dr Henan Dh Skheel. Department Of . Obs&Gyn. 2...
Anticoagulants Did You Know
Anticoagulants Did You Know
by PrincessPeach
?. That . major bleeding . occurs in about . 6.5% ...
Diagnosis & Management
Diagnosis & Management
by iris
of Heparin-Induced Thrombocytopenia. An Educationa...